Important Dates
Early Bird Registration :22nd September 2026
Paper Submission Deadline :27th September 2026
Last Date of Registration : 7th October 2026
Date of Conference : 22nd - 23rd October 2026
Conference Session Tracks
Aligned with
UN Sustainable Development Goals
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals.
SDG 3 — Good Health and Well-being
SDG 4 — Quality Education
SDG 9 — Industry, Innovation and Infrastructure
SDG 10 — Reduced Inequalities
SDG 16 — Peace, Justice and Strong Institutions
SDG 17 — Partnerships for the Goals
Track 01
Innovations in Molecular Diagnostics
This track will explore the latest advancements in molecular diagnostic techniques and their applications in hematology and oncology. Emphasis will be placed on how these innovations can enhance patient outcomes through early detection and personalized treatment strategies.
Track 02
Translational Research in Hematology
This session will focus on the translation of laboratory findings into clinical applications within hematology. Participants will discuss the challenges and successes of bridging the gap between research and patient care.
Track 03
Therapeutic Strategies in Cancer Treatment
This track will examine current and emerging therapeutic strategies for treating hematological malignancies. Discussions will include targeted therapies, immunotherapy, and combination treatment approaches.
Track 04
Clinical Trials in Hematology and Oncology
This session will highlight the design and implementation of clinical trials specifically targeting hematological cancers. Participants will share insights on trial methodologies, patient recruitment, and regulatory considerations.
Track 05
Patient Care and Quality of Life
This track will address the importance of patient-centered care in hematology and oncology. Topics will include psychosocial support, symptom management, and strategies to improve the quality of life for patients.
Track 06
Laboratory Innovations in Hematology
This session will showcase cutting-edge laboratory techniques and technologies that are transforming hematology diagnostics and research. Emphasis will be placed on automation, high-throughput screening, and novel biomarker discovery.
Track 07
Collaboration in Cancer Research
This track will explore the significance of interdisciplinary collaboration in advancing cancer research. Participants will discuss successful models of partnership between academia, industry, and clinical practice.
Track 08
Understanding Disease Mechanisms
This session will delve into the underlying biological mechanisms of hematological diseases. Presentations will focus on genetic, epigenetic, and environmental factors contributing to disease pathogenesis.
Track 09
Emerging Trends in Hematology
This track will highlight recent trends and future directions in hematology research and treatment. Topics will include novel therapies, advancements in genetic research, and the impact of technology on patient management.
Track 10
Ethical Considerations in Hematology and Oncology
This session will address the ethical challenges faced in hematology and oncology research and practice. Discussions will include informed consent, equity in clinical trials, and the implications of personalized medicine.
Track 11
Global Perspectives on Hematology and Oncology
This track will provide a platform for discussing global health challenges and disparities in hematology and oncology. Participants will share insights on international collaborations and strategies to improve access to care.